Funding Funded Projects DAGVADORJ, Nergui et al.: Targeting of the WT191-138 Fragment to Human Dendritic Cells Improves Leukemia-Specific T-Cell Responses Providing an Alternative Approach to WT1-based Vaccination.

DAGVADORJ, Nergui et al.: Targeting of the WT191-138 Fragment to Human Dendritic Cells Improves Leukemia-Specific T-Cell Responses Providing an Alternative Approach to WT1-based Vaccination.

– In: Cancer Immunol Immunother. 66,3. 2016. S. 319–332.

DAGVADORJ, Nergui et al.: Targeting of the WT191-138 Fragment to Human Dendritic Cells Improves Leukemia-Specific T-Cell Responses Providing an Alternative Approach to WT1-based Vaccination.

Newsletter Anmeldung

Newsletter Abmeldung